Clone

Clone

Early Stage

Designing synthetic humans capable of performing any task assigned

Designing synthetic humans capable of performing any task assigned

Overview

Raised to Date: Raised: $0

Total Commitments ($USD)

Platform

Republic

Start Date

02/26/2023

Close Date

04/24/2023

Min. Goal
$25,000
Max. Goal
$1,235,000
Min. Investment

$100

Security Type

SAFE

Series

Seed

SEC Filing Type

RegCF    Open SEC Filing

Valuation Cap

$30,000,000

Discount

0%

Rolling Commitments ($USD)

Status
Not Funded
Reporting Date

04/25/2023

Days Remaining
Not Funded
% of Min. Goal
Not Funded
% of Max. Goal
Not Funded
Likelihood of Max
Not Funded
Avg. Daily Raise

$0

Momentum
Not Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2021

Industry

Industrial Services

Tech Sector

AutomationTech

Distribution Model

B2B/B2C

Margin

Low

Capital Intensity

High

Location

New York, New York

Business Type

Growth

Clone, with a valuation of $30 million, is raising funds on Republic. The company is using its technology to design synthetic humans capable of performing any task. Currently, the business has created a clone of the human hand using functional biomimetic design, monolithic tendon muscles, soft tissues, and molded bones. Based on the experience gained from creating the synthetic hand, Clone aims to build a whole synthetic human body. Dhanush Radhakrishnan and Lukasz Kozlik founded Clone in October 2021. The current crowdfunding campaign has a minimum target of $25,000 and a maximum target of $1.24 million. The campaign proceeds will be used for technology and product development, production, and infrastructure.

Summary Profit and Loss Statement

FY 2021 FY 2020

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-2,020

$0

Summary Balance Sheet

FY 2021 FY 2020

Cash

$298,065

$0

Accounts Receivable

$0

$0

Total Assets

$298,065

$0

Short-Term Debt

$0

$0

Long-Term Debt

$300,000

$0

Total Liabilities

$300,000

$0

Financials as of: 02/26/2023
Create a free account today to gain access to KingsCrowd analytics.

Funding data not publicly available

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.

Create your first portfolio

Create your own startup investment portfolio on KingsCrowd.

Track all of your startup investments in one place using our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Clone on Republic 2023
Platform: Republic
Security Type: SAFE
Valuation: $30,000,000

Follow company

Follow Clone on Republic 2023

Buy Clone's Deal Report

Warning: according to the close date for this deal, Clone may no longer be accepting investments.

Clone Deal Report

Get KingsCrowd’s comprehensive report on Clone including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Clone is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Clone deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge